Why the introduction of telehealth kiosks in employers is part of a trend of increased patient visibility.
The number of members joining Health Care Sharing Ministries are swelling. One reason may be that consumers don’t understand such organizations don’t provide actual health insurance.
With a record number of innovative drugs queued for FDA approval, managed healthcare executives have an eye toward innovative new products that tackle difficult conditions.
With a country-wide focus on reducing the cost of prescription drugs, managed healthcare executives make their forecasts concerning the future of list prices.
The Trump Administration is calling for better price transparency to help control healthcare costs—but is publishing list prices enough?
How the right benefit design can help increase patient engagement and adherence to key maintenance therapies.
The rare disease community struggles to balance care with costs.
With the future of the ACA still in question, new studies suggest its provision for Medicaid expansion has helped to correct healthcare disparities in cancer.
Managed Healthcare Executive’s Managed Care Pharmacy Survey identifies different ways specialty pharmacy stakeholders believe they can reduce industry costs moving forward.
How will payers, providers, and patients respond when a $2 million drug drops into the market?